With $190K in ARRA Funding, 23andMe to Validate Web-based Platform to Spur PGx Collaborations

The company aims to show that its web-based, customer-reported data-gathering model yields results comparable to traditional research methods — both in terms of the accuracy of phenotypic data reported by customers, as well as the overall ability of the approach to replicate known associations between genes and drug response.